These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 6684469

  • 1. Treatment of chronic dyskinesia with CDP-choline.
    Arranz J, Ganoza C.
    Arzneimittelforschung; 1983; 33(7A):1071-3. PubMed ID: 6684469
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Effect of CDP-choline on senile mental deterioration. Multicenter experience on 237 cases].
    Serra F, Diaspri GP, Gasbarrini A, Giancane S, Rimondi A, Tamè MR, Sakellaridis E, Bernardi M, Gasbarrini G.
    Minerva Med; 1990 Jun; 81(6):465-70. PubMed ID: 2193245
    [Abstract] [Full Text] [Related]

  • 4. CDP-choline for the treatment of tardive dyskinesia: a small negative series.
    Gelenberg AJ, Wojcik J, Falk WE, Bellinghausen B, Joseph AB.
    Compr Psychiatry; 1989 Jun; 30(1):1-4. PubMed ID: 2647398
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of oral CDP-choline on experimental withdrawal syndrome.
    Tornos ME, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983 Jun; 33(7A):1018-21. PubMed ID: 6684454
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CDP-choline: pharmacological and clinical review.
    Secades JJ, Frontera G.
    Methods Find Exp Clin Pharmacol; 1995 Oct; 17 Suppl B():1-54. PubMed ID: 8709678
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacological study of oral CDP-choline. Interaction with oxotremorine on the parasympathetic system.
    Tornos ME, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983 Oct; 33(7A):1026-9. PubMed ID: 6684457
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of the effects of citicoline in chronic cerebrovascular diseases].
    Sinforiani E, Trucco M, Pacchetti C, Gualtieri S.
    Minerva Med; 1986 Jan 14; 77(1-2):51-7. PubMed ID: 3511406
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [An open study on the clinical efficacy of citicoline in patients with chronic cerebral vasculopathy].
    Rossi M, Zanardi M.
    Clin Ter; 1993 Feb 14; 142(2):141-4. PubMed ID: 8472528
    [Abstract] [Full Text] [Related]

  • 14. CDP-choline: 6-month study on toxicity in dogs.
    Romero A, Grau T, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983 Feb 14; 33(7A):1038-42. PubMed ID: 6684461
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dissimilar effects in acute toxicity studies of CDP-choline and choline.
    Agut J, Font E, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983 Feb 14; 33(7A):1016-8. PubMed ID: 6684453
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of oral CDP-choline on acrylamide-induced lesion.
    Agut J, Font E, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983 Feb 14; 33(7A):1029-33. PubMed ID: 6684458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.